Targeting the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein for the Treatment of Cystic Fibrosis
Abdel-Magid, A.F.
Acs Medicinal Chemistry Letters 7(8): 725-727
2016
ISSN/ISBN: 1948-5875
PMID: 27563392
DOI: 10.1021/acsmedchemlett.6b00258
Accession: 058974970
PDF emailed within 0-6 h: $19.90
Related References
Pesci, E.; Bettinetti, L.; Fanti, P.; Galietta, L.J.V.; La Rosa, S.; Magnoni, L.; Pedemonte, N.; Sardone, G.Luca.; Maccari, L. 2015: Novel Hits in the Correction of ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein: Synthesis, Pharmacological, and ADME Evaluation of Tetrahydropyrido[4,3-d]pyrimidines for the Potential Treatment of Cystic Fibrosis Journal of Medicinal Chemistry 58(24): 9697-9711Carter, C.J. 2011: Pathogen and autoantigen homologous regions within the cystic fibrosis transmembrane conductance regulator (CFTR) protein suggest an autoimmune treatable component of cystic fibrosis Fems Immunology and Medical Microbiology 62(2): 197-214
Ewence, A.; Eruchie, C.; Higton, A.; Ho, T. 2013: P101Does Ivacaftor improve objective measurements of health in patients with the G551D cystic fibrosis transmembrane conductance regulator (Cftr) protein mutation? The experience of a Uk cystic fibrosis centre Thorax 68(Suppl 3): A120.2-A120
Ferreira, V.F.C.; Oliveira, B.L.; Santos, J.ão.D.; Correia, J.ão.D.G.; Farinha, C.M.; Mendes, F. 2018: Targeting of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein with a Technetium-99m Imaging Probe Chemmedchem 13(14): 1469-1478
Tamanini, A.; Fabbri, E.; Jakova, T.; Gasparello, J.; Manicardi, A.; Corradini, R.; Finotti, A.; Borgatti, M.; Lampronti, I.; Munari, S.; Dechecchi, M.C.; Cabrini, G.; Gambari, R. 2021: A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 Biomedicines 9(2)
Srivastava, M.; Eidelman, O.; Pollard, H.B. 1999: Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis Molecular Medicine 5(11): 753-767
Zhang, S.; Shrestha, C.L.; Kopp, B.T. 2018: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function Scientific Reports 8(1): 17066
Mathew, A.; Dirawi, M.; Abou Tayoun, A.; Popatia, R. 2021: A Rare Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation Associated with Typical Cystic Fibrosis in an Arab Child Cureus 13(2): E13526
Srivastava, M.; Eidelman, O.; Pollard, H., B. 1999: Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis Molecular Medicine (New York) 5(11): 753-767
Wang, W.; Okayama, H.; Shirato, K. 1996: Genotypes of cystic fibrosis (CF) reported in the world and polymorphisms of cystic fibrosis transmembrane conductance regulator (CFTR) gene in Japanese Nihon Rinsho. Japanese Journal of Clinical Medicine 54(2): 525-532
Andersson, C.; Dragomir, A.; Hjelte, L.; Roomans, G.M. 2002: Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes Clinical Science 103(4): 417-424
Andersson, C.; Dragomir, A.; Hjeltef, L.; Roomans, G.M. 2002: Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes Clinical Science (1979) 103(4): 417-424
Andersson, C.; Dragomir, A.; Hjelte, L.; Roomans, G.M. 2002: Cystic fibrosis transmembrane conductance regulator (Cftr) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes Clinical Science 103(4): 417-424
Schippa, S.; Iebba, V.; Santangelo, F.; Gagliardi, A.; De Biase, R.V.; Stamato, A.; Bertasi, S.; Lucarelli, M.; Conte, M.P.; Quattrucci, S. 2013: Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients Plos one 8(4): E61176
Cai, Z.; Taddei, A.; Sheppard, D.N. 2005: Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel Journal of Biological Chemistry 281(4): 1970-1977
Fukuda, R.; Okiyoneda, T. 2020: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis Pharmaceuticals 13(4)
Bruch, B.A.; Singh, S.B.; Ramsey, L.J.; Starner, T.D. 2018: Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients Pediatric Pulmonology 53(8): 1035-1039
Cai, Z.; Taddei, A.; Sheppard, D., N. 2006: Differential Sensitivity of the Cystic Fibrosis (CF)-associated Mutants G551D and G1349D to Potentiators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl superscript - Channel Journal of Biological Chemistry 281(4): 1970-1977
Puchelle, E.; Gaillard, D.; Plotkowski, C.; Fuchey, C.; Nakagawa, N.; Dalemans, W. 1991: Immunohistochemical study of cystic fibrosis respiratory epithelial cells using monoclonal antibodies directed towards peptides corresponding to the cystic fibrosis transmembrane conductance regulator cftr American Review of Respiratory Disease 143(4 Part 2): A293
Maiuri, L.; Raia, V.; Piacentini, M.; Tosco, A.; Villella, V.R.; Kroemer, G. 2019: Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease Oncotarget 10(43): 4492-4500